Picture of Panacea Life Sciences Holdings logo

PLSH Panacea Life Sciences Holdings Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Panacea Life Sciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments0.0180.0253.811.110.116
Net Total Accounts Receivable
Net Total Receivables0.20200.7450.7060.264
Total Inventory
Prepaid Expenses
Total Current Assets2.430.0519.16.384.66
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment2.650.0212.410.910.3
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets9.80.07123.819.518
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities4.194.910.115.119.4
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities5.583.0916.721.626.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity4.22-3.027.1-2.14-8.29
Total Liabilities & Shareholders' Equity9.80.07123.819.518
Total Common Shares Outstanding
Total Preferred Shares Outstanding